Breast Lesion Localization Methods Market By Type (Wire, Radioisotope [Radio Occult], Magnetic), Usage (Tumor Identification, Sentinel Lymph Node [Lumpectomy]), End User Preference Survey (Selection Criteria, Replacement Trend) - Global Forecast to 2025

乳房病変位置特定法の世界市場予測:種類別(ワイヤー、ラジオアイソトープ[ラジオオカルト]、磁気)、使用別(腫瘍特定、センチネルリンパ節[乳腺腫瘍摘出術])、エンドユーザー別(選択基準、交換傾向)

◆タイトル:Breast Lesion Localization Methods Market By Type (Wire, Radioisotope [Radio Occult], Magnetic), Usage (Tumor Identification, Sentinel Lymph Node [Lumpectomy]), End User Preference Survey (Selection Criteria, Replacement Trend) - Global Forecast to 2025
◆商品コード:MD 4236
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年7月16日
◆ページ数:157
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥519,750見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥698,250見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥855,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社は乳房病変位置特定法の世界市場が2020年3974万4千ドルから2025年5750万9千ドルまで、年平均7.5%成長すると予想しています。本調査レポートでは、乳房病変位置特定法の世界市場について、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、産業インサイト、種類別(ワイヤーローカリゼーション、放射性同位元素ローカリゼーション、磁気ローカリゼーション、電磁ローカリゼーション、その他)分析、使用別(センチネルリンパ節識別、腫瘍同定)分析、地域別分析、競争状況、企業情報などを総合的、多面的に調査・分析しました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・産業インサイト
・乳房病変位置特定法の世界市場規模:種類別(ワイヤーローカリゼーション、放射性同位元素ローカリゼーション、磁気ローカリゼーション、電磁ローカリゼーション、その他)
・乳房病変位置特定法の世界市場規模:使用別(センチネルリンパ節識別、腫瘍同定)
・乳房病変位置特定法の世界市場規模:地域別
・競争状況
・企業情報

“The increasing incidence of breast cancer, rising awareness about benefits of early diagnosis and number of breast cancer surgeries are expected to drive the overall growth of the breast lesion localization methods market.”
The breast lesion localization methods market is expected to grow at a CAGR of 7.5% in the forecast period.
Market for breast lesion localization methods is expected to grow from 3,974.4 thousands of procedures in 2020 to 5750.9 thousands of procedures by 2025, at a CAGR of 7.5% during the forecast period. The breast lesion localization methods market is driven primarily by the increasing incidence of breast cancer, rising number of breast cancer surgeries, and growing awareness on the early detection of breast cancer. However, uncertainty in regulatory approval procedures is expected to restrain the growth of this market during the forecast period.

“The Covid-19 pandemic has largely impacted healthcare delivery globally since December 2019.”
Non-essential procedures related to breast cancer care and routine breast screening programs have been postponed in many countries as healthcare resources are diverted to handle the pandemic crisis. The selection of the type of breast lesion localization method in the current scenario and in the post lockdown period can be considered from three aspects: time taken for procedure, re-operation/re-excision rates and cost of the breast lesion localization device.

“Revised guidelines for breast cancer care have been suggested by cancer organizations and oncologists in most regions, most of which focus on minimizing outpatient and inpatient admissions and staggering schedules to reduce patient influx daily.”
The time taken for the procedure becomes crucial in this scenario for the convenience of patients and healthcare providers and also to lower the chances of spread of viral infection. In this case, healthcare providers may not favor wire guided localization (WGL) procedures as they require almost twice as much time as other procedures. Moreover, the chances of re-excision in case of this procedure is also high.

“The wire localization segment held the largest share of the breast lesion localization methods market in 2020.”
Based on type, the breast lesion localization methods market is divided into five major segments—wire localization, isotope localization, magnetic localization, electromagnetic localization, and others. The wire localization segment accounted for the largest share of the breast lesion localization methods market in 2020. The large share of this segment is attributed to its accuracy in abnormal tissue localization, minimum removal of normal tissues, minimal scarring, and the availability of reimbursement for breast lesion localization devices.

“Asia Pacific accounted the largest share and is projected to grow at the highest CAGR during the forecast period.”
The Asia Pacific accounted the largest share and is projected to record the highest growth in the breast lesion localization methods market during the forecast period. The rapidly increasing patient population, increasing healthcare expenditure, improving healthcare infrastructure, high government spending on breast cancer research, and increasing awareness are the major factors supporting the growth of the Asia Pacific breast lesion localization methods market.

The report also contains a detailed analysis of end-user preference for the adoption of different breast lesion localization methods. The research findings cited in the report encapsulates the important selection criteria for breast lesion localization methods from an end-user point of view. It analyses importance given to the particular criteria while selecting a breast lesion localization methods. Important criteria for the selection of breast lesion localization methods include detection and success rate, re-excision rate, cost, mean localization time, effectiveness, safety, and ease of use.

In-depth interviews were conducted with chief executive officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the breast lesion localization method market.
By Company: Tier 1: 60%, Tier 2: 30%, and Tier 3: 10%
By Designation: C-level Executives: 47%, Directors: 33%, and Others: 20%
By Region: North America: 57%, Europe: 26%, APAC: 9%, and the RoW: 8%

Some of the key players in the breast lesion localization methods market are Hologic Inc. (US), Laurane Medical (US), Mermaid Medical A/S (Denmark), IZI Medical Products (US), Matek Medical Inc. (Turkey), Tsunami Medical Inc. (Italy), BPB Medica (Italy), Sirius Medical BV (Netherlands), Molli Surgical Inc. (Canada), Argon Medical Devices (US), B.D. Company (US), Cianna Medical (US), Endomagnetics Ltd. (UK), Health Beacons, Inc. (Australia), Intra-Medical Imaging LLC (US), IsoAid, LLC (US), Leica Biosystems (Germany), SOMATEX Medical Technologies GmbH (Germany), SurgicEye GmbH (Germany) and Ranfac Corporation ((US). The study includes an in-depth competitive analysis of these key players in the breast lesion localization methods market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:
The market study covers the breast lesion localization methods market across various segments. It aims at estimating the market size (in terms of volume) and the growth potential of this market across different segments by type, usage, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of breast lesion localization procedures market and its subsegments. This report will help stakeholders to understand the competitive landscape, gain insights to better position their businesses, and plan suitable go-to-market strategies. The report will also help stakeholders understand the pulse of the market and provide information on key market drivers, restraints, and opportunities.

【レポートの目次】

1 INTRODUCTION 26
1.1 OBJECTIVES OF THE STUDY 26
1.2 MARKET DEFINITION 26
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS IN THE BREAST LESION LOCALIZATION MARKET 26
1.3 MARKET SCOPE 27
1.3.1 MARKETS COVERED 27
1.3.2 YEARS CONSIDERED FOR THE STUDY 27
1.4 CURRENCY 28
TABLE 1 STANDARD CURRENCY CONVERSION RATE 28
1.5 LIMITATIONS 28
1.6 STAKEHOLDERS 28
1.7 SUMMARY OF CHANGES 29
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
FIGURE 1 RESEARCH DESIGN 30
2.1.1 SECONDARY DATA 31
2.1.1.1 Key data from secondary sources 31
2.1.2 PRIMARY DATA 32
FIGURE 2 PRIMARY SOURCES FOR THE BREAST LESION LOCALIZATION METHODS MARKET 32
2.1.2.1 Key data from primary sources 33
FIGURE 3 BREAKDOWN OF PRIMARIES: GLOBAL BREAST LESION LOCALIZATION METHODS MARKET 33
2.2 MARKET SIZE ESTIMATION 34
2.2.1 MARKET SIZING APPROACH FOR THE BREAST LESION LOCALIZATION METHODS MARKET: DEMAND-SIDE APPROACH (APPROACH 1) 34
FIGURE 4 MARKET SIZE ESTIMATION: DEMAND-SIDE APPROACH (APPROACH 1) 34
2.2.2 MARKET SIZING APPROACH FOR THE BREAST LESION LOCALIZATION METHODS MARKET: DEMAND-SIDE (APPROACH 2) 36
FIGURE 5 MARKET SIZE ESTIMATION: DEMAND-SIDE APPROACH (APPROACH 2) 36
FIGURE 6 MARKET SIZE ESTIMATION: DEMAND-SIDE APPROACH (APPROACH 3) 37
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 39
FIGURE 7 DATA TRIANGULATION METHODOLOGY 39
2.3.1 ASSUMPTIONS 40

3 EXECUTIVE SUMMARY 41
FIGURE 8 BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE,
2020 VS. 2025 (THOUSAND PROCEDURES) 41
FIGURE 9 RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE,
2020 VS. 2025 (THOUSAND PROCEDURES) 42
FIGURE 10 BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE,
2020 VS. 2025 (THOUSAND PROCEDURES) 43
FIGURE 11 GEOGRAPHIC SNAPSHOT: BREAST LESION LOCALIZATION METHODS MARKET 44
4 PREMIUM INSIGHTS 45
4.1 BREAST LESION LOCALIZATION METHODS MARKET OVERVIEW 45
FIGURE 12 RISING AWARENESS IS EXPECTED TO DRIVE MARKET GROWTH 45
4.2 ASIA PACIFIC: BREAST LESION LOCALIZATION METHODS MARKET, 2019 46
FIGURE 13 WIRE LOCALIZATION HELD THE LARGEST SHARE OF THE ASIA PACIFIC BREAST LESION LOCALIZATION METHODS MARKET IN 2019 46
4.3 BREAST LESION LOCALIZATION METHODS MARKET: GEOGRAPHIC MIX 47
FIGURE 14 ASIA PACIFIC WILL CONTINUE TO DOMINATE THE BREAST LESION LOCALIZATION METHODS MARKET TILL 2025 47
5 MARKET OVERVIEW 48
5.1 INTRODUCTION 48
5.2 MARKET DYNAMICS 48
FIGURE 15 BREAST LESION LOCALIZATION METHODS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 48
5.3 DRIVERS 49
5.3.1 GROWING INCIDENCE OF BREAST CANCER 49
TABLE 2 TOP 10 COUNTRIES WITH THE HIGHEST INCIDENCE OF
BREAST CANCER, 2018 49
FIGURE 16 INCIDENCE OF BREAST CANCER (MILLION CASES) FROM 2012–2025 50
5.3.2 INCREASING NUMBER OF BREAST CANCER SURGERIES 50
FIGURE 17 ESTIMATED NUMBER OF BREAST CANCER SURGERIES (MILLION CASES) FROM 2012–2024 50
5.3.3 INCREASING AWARENESS ON THE EARLY DETECTION OF BREAST CANCER 51
5.4 RESTRAINTS 51
5.4.1 UNCERTAINTY IN REGULATORY APPROVAL PROCEDURES 51
5.5 OPPORTUNITIES 52
5.5.1 EMERGING ECONOMIES OFFER HIGH GROWTH POTENTIAL 52
5.5.2 INCREASING ADOPTION OF TECHNOLOGICALLY ADVANCED LOCALIZATION PROCEDURES 52
5.6 CHALLENGES 53
5.6.1 SHORTAGE OF ONCOLOGISTS 53
5.7 IMPACT OF COVID-19 ON THE BREAST LESION LOCALIZATION MARKET: RESTRUCTURING OF BREAST CANCER CARE 53
5.8 ADJACENT MARKET TABLES 54
6 INDUSTRY INSIGHTS 55
6.1 INDUSTRY TRENDS 55
6.1.1 ELECTROMAGNETIC WAVES FOR LOCALIZATION OF BREAST LESIONS 55
6.1.2 RADIOFREQUENCY IDENTIFICATION IN BREAST LESION LOCALIZATION 55
6.1.3 MACHINE LEARNING ALGORITHMS FOR COMPUTER-AIDED BREAST LESION DETECTION 55
6.1.4 REIMBURSEMENT GUIDELINES FOR BREAST LESION LOCALIZATION DEVICE PLACEMENT 56
FIGURE 18 CODES, DEFINITIONS, & PHYSICIAN PAYMENT FOR BREAST LESION LOCALIZATION PROCEDURES (MEDICARE & MEDICAID SERVICES – HOPPS) 57
FIGURE 19 REIMBURSEMENT FOR BREAST LESION LOCALIZATION DEVICE PLACEMENT, 2014–2018 57
7 BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE 58
7.1 INTRODUCTION 59
TABLE 3 BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE,
2017–2019 (THOUSAND PROCEDURES) 59
TABLE 4 BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE,
2020–2025 (THOUSAND PROCEDURES) 59
TABLE 5 BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE,
2017–2019 (USD MILLION) 60
TABLE 6 BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE,
2020–2025 (USD MILLION) 60
7.2 WIRE LOCALIZATION 60
TABLE 7 WIRE LOCALIZATION METHODS MARKET, BY REGION,
2017–2019 (THOUSAND PROCEDURES) 61
TABLE 8 WIRE LOCALIZATION METHODS MARKET, BY REGION,
2020–2025 (THOUSAND PROCEDURES) 61
7.3 RADIOISOTOPE LOCALIZATION 61
TABLE 9 RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE,
2017–2019 (THOUSAND PROCEDURES) 61
TABLE 10 RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE,
2020–2025 (THOUSAND PROCEDURES) 62
TABLE 11 RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE,
2017–2019 (USD MILLION) 62
TABLE 12 RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE,
2020–2025 (USD MILLION) 62
TABLE 13 RADIOISOTOPE LOCALIZATION METHODS MARKET, BY REGION,
2017–2019 (THOUSAND PROCEDURES) 62
TABLE 14 RADIOISOTOPE LOCALIZATION METHODS MARKET, BY REGION,
2020–2025 (THOUSAND PROCEDURES) 63
TABLE 15 RADIOISOTOPE LOCALIZATION METHODS MARKET, BY REGION,
2017–2019 (USD MILLION) 63
TABLE 16 RADIOISOTOPE LOCALIZATION METHODS MARKET, BY REGION,
2020–2025 (USD MILLION) 63
7.3.1 RADIOGUIDED OCCULT LESION LOCALIZATION (ROLL) 64
TABLE 17 RADIOGUIDED OCCULT LESION LOCALIZATION MARKET, BY REGION,
2017–2019 (THOUSAND PROCEDURES) 64
TABLE 18 RADIOGUIDED OCCULT LESION LOCALIZATION MARKET, BY REGION,
2020–2025 (THOUSAND PROCEDURES) 64
TABLE 19 RADIOGUIDED OCCULT LESION LOCALIZATION MARKET, BY REGION,
2017–2019 (USD MILLION) 65
TABLE 20 RADIOGUIDED OCCULT LESION LOCALIZATION MARKET, BY REGION,
2020–2025 (USD MILLION) 65
7.3.2 RADIOACTIVE SEED LOCALIZATION (RSL) 65
TABLE 21 RADIOACTIVE SEED LOCALIZATION MARKET, BY REGION,
2017–2019 (THOUSAND PROCEDURES) 66
TABLE 22 RADIOACTIVE SEED LOCALIZATION MARKET, BY REGION,
2020–2025 (THOUSAND PROCEDURES) 66
TABLE 23 RADIOACTIVE SEED LOCALIZATION MARKET, BY REGION,
2017–2019 (USD MILLION) 66
TABLE 24 RADIOACTIVE SEED LOCALIZATION MARKET, BY REGION,
2020–2025 (USD MILLION) 67
7.4 MAGNETIC LOCALIZATION 67
TABLE 25 MAGNETIC LOCALIZATION METHODS MARKET, BY REGION,
2017–2019 (THOUSAND PROCEDURES) 67
TABLE 26 MAGNETIC LOCALIZATION METHODS MARKET, BY REGION,
2020–2025 (THOUSAND PROCEDURES) 68
TABLE 27 MAGNETIC LOCALIZATION METHODS MARKET, BY REGION,
2017–2019 (USD MILLION) 68
TABLE 28 MAGNETIC LOCALIZATION METHODS MARKET, BY REGION,
2020–2025 (USD MILLION) 68
7.5 ELECTROMAGNETIC LOCALIZATION 69
7.6 OTHER LOCALIZATION METHODS 69
TABLE 29 OTHER LOCALIZATION METHODS MARKET, BY REGION,
2017–2019 (THOUSAND PROCEDURES) 69
TABLE 30 OTHER LOCALIZATION METHODS MARKET, BY REGION,
2020–2025 (THOUSAND PROCEDURES) 70
TABLE 31 OTHER LOCALIZATION METHODS MARKET, BY REGION,
2017–2019 (USD MILLION) 70
TABLE 32 OTHER LOCALIZATION METHODS MARKET, BY REGION,
2020–2025 (USD MILLION) 70
7.7 COVID-19 IMPACT ON THE BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE 71
8 BREAST LESION LOCALIZATION MARKET, BY USAGE 72
8.1 INTRODUCTION 73
TABLE 33 BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE,
2017–2019 (THOUSAND PROCEDURES) 73
TABLE 34 BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE,
2020–2025 (THOUSAND PROCEDURES) 73
8.2 SENTINEL LYMPH NODE IDENTIFICATION 73
TABLE 35 BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE IDENTIFICATION, BY REGION, 2017–2019 (THOUSAND PROCEDURES) 74
TABLE 36 BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE IDENTIFICATION, BY REGION, 2020–2025 (THOUSAND PROCEDURES) 74
TABLE 37 NORTH AMERICA: BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE IDENTIFICATION, BY COUNTRY, 2017–2019 (THOUSAND PROCEDURES) 74
TABLE 38 NORTH AMERICA: BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE IDENTIFICATION, BY COUNTRY, 2020–2025 (THOUSAND PROCEDURES) 75
TABLE 39 BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE IDENTIFICATION, BY SURGERY TYPE, 2017–2019 (THOUSAND PROCEDURES) 75
TABLE 40 BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE IDENTIFICATION, BY SURGERY TYPE, 2020–2025 (THOUSAND PROCEDURES) 75
8.2.1 LUMPECTOMY 75
8.2.1.1 High survival rates favor the adoption of lumpectomy 75
TABLE 41 SENTINEL LYMPH NODE IDENTIFICATION MARKET FOR LUMPECTOMY,
BY REGION, 2017–2019 (THOUSAND PROCEDURES) 76
TABLE 42 SENTINEL LYMPH NODE IDENTIFICATION MARKET FOR LUMPECTOMY,
BY REGION, 2020–2025 (THOUSAND PROCEDURES) 76
TABLE 43 NORTH AMERICA: SENTINEL LYMPH NODE IDENTIFICATION MARKET FOR LUMPECTOMY, BY COUNTRY, 2017–2019 (THOUSAND PROCEDURES) 76
TABLE 44 NORTH AMERICA: SENTINEL LYMPH NODE IDENTIFICATION MARKET FOR LUMPECTOMY, BY COUNTRY, 2020–2025 (THOUSAND PROCEDURES) 77
8.2.2 MASTECTOMY 77
8.2.2.1 There is a low risk of cancer recurrence in mastectomy 77
TABLE 45 GLOBAL NUMBER OF MASTECTOMY PROCEDURES PER 10,000 POPULATION, 2012–2024 77
TABLE 46 SENTINEL LYMPH NODE IDENTIFICATION MARKET FOR MASTECTOMY,
BY REGION, 2017–2019 (THOUSAND PROCEDURES) 77
TABLE 47 SENTINEL LYMPH NODE IDENTIFICATION MARKET FOR MASTECTOMY,
BY REGION, 2020–2025 (THOUSAND PROCEDURES) 78
TABLE 48 NORTH AMERICA: SENTINEL LYMPH NODE IDENTIFICATION MARKET FOR MASTECTOMY, BY COUNTRY, 2017–2019 (THOUSAND PROCEDURES) 78
TABLE 49 NORTH AMERICA: SENTINEL LYMPH NODE IDENTIFICATION MARKET FOR MASTECTOMY, BY COUNTRY, 2020–2025 (THOUSAND PROCEDURES) 78
8.3 TUMOR IDENTIFICATION 79
8.3.1 INCREASING FOCUS ON EARLY BREAST CANCER DETECTION DRIVING THE GROWTH OF THE TUMOR IDENTIFICATION SEGMENT 79
TABLE 50 BREAST LESION LOCALIZATION METHODS MARKET FOR TUMOR IDENTIFICATION, BY REGION, 2017–2019 (THOUSAND PROCEDURES) 79
TABLE 51 BREAST LESION LOCALIZATION METHODS MARKET FOR TUMOR IDENTIFICATION, BY REGION, 2020–2025 (THOUSAND PROCEDURES) 79
TABLE 52 NORTH AMERICA: BREAST LESION LOCALIZATION METHODS MARKET FOR TUMOR IDENTIFICATION, BY COUNTRY, 2017–2019 (THOUSAND PROCEDURES) 80
TABLE 53 NORTH AMERICA: BREAST LESION LOCALIZATION METHODS MARKET FOR TUMOR IDENTIFICATION, BY COUNTRY, 2020–2025 (THOUSAND PROCEDURES) 80
9 BREAST LESION LOCALIZATION METHODS MARKET, BY REGION 81
9.1 INTRODUCTION 82
TABLE 54 BREAST LESION LOCALIZATION METHODS MARKET, BY REGION,
2017–2019 (THOUSAND PROCEDURES) 82
TABLE 55 BREAST LESION LOCALIZATION METHODS MARKET, BY REGION,
2020–2025 (THOUSAND PROCEDURES) 82
9.2 ASIA PACIFIC 83
FIGURE 20 ASIA PACIFIC REGION: BREAST LESION LOCALIZATION METHODS MARKET SNAPSHOT 83
9.2.1 COVID-19 IMPACT ON THE BREAST LESION LOCALIZATION METHODS MARKET IN THE ASIA PACIFIC 84
TABLE 56 ASIA PACIFIC: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017–2019 (THOUSAND PROCEDURES) 84
TABLE 57 ASIA PACIFIC: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2020–2025 (THOUSAND PROCEDURES) 85
TABLE 58 ASIA PACIFIC: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2017–2019 (THOUSAND PROCEDURES) 85
TABLE 59 ASIA PACIFIC: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2020–2025 (THOUSAND PROCEDURES) 85
TABLE 60 ASIA PACIFIC: BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017–2019 (THOUSAND PROCEDURES) 85
TABLE 61 ASIA PACIFIC: BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2020–2025 (THOUSAND PROCEDURES) 86
TABLE 62 ASIA PACIFIC: BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE IDENTIFICATION, BY SURGERY TYPE,
2017–2019 (THOUSAND PROCEDURES) 86
TABLE 63 ASIA PACIFIC: BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE IDENTIFICATION, BY SURGERY TYPE,
2020–2025 (THOUSAND PROCEDURES) 86
TABLE 64 ASIA PACIFIC: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017–2019 (USD MILLION) 86
TABLE 65 ASIA PACIFIC: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2020–2025 (USD MILLION) 87
9.3 EUROPE 87
9.3.1 COVID-19 IMPACT ON THE BREAST LESION LOCALIZATION METHODS MARKET IN EUROPE 87
9.3.2 GERMANY 88
9.3.3 FRANCE 88
9.3.4 UK 89
9.3.5 REST OF EUROPE 89
FIGURE 21 EUROPE: BREAST LESION LOCALIZATION METHODS MARKET SNAPSHOT 90
TABLE 66 EUROPE: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017–2019 (THOUSAND PROCEDURES) 90
TABLE 67 EUROPE: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2020–2025 (THOUSAND PROCEDURES) 91
TABLE 68 EUROPE: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE,
2017–2019 (THOUSAND PROCEDURES) 91
TABLE 69 EUROPE: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE,
2020–2025 (THOUSAND PROCEDURES) 91
TABLE 70 EUROPE: BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017–2019 (THOUSAND PROCEDURES) 91
TABLE 71 EUROPE: BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2020–2025 (THOUSAND PROCEDURES) 92
TABLE 72 EUROPE: BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE IDENTIFICATION, BY SURGERY TYPE, 2017–2019 (THOUSAND PROCEDURES) 92
TABLE 73 EUROPE: BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE IDENTIFICATION, BY SURGERY TYPE, 2020–2025 (THOUSAND PROCEDURES) 92
TABLE 74 EUROPE: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017–2019 (USD MILLION) 92
TABLE 75 EUROPE: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2020–2025 (USD MILLION) 93
9.4 NORTH AMERICA 93
9.4.1 COVID-19 IMPACT ON THE BREAST LESION LOCALIZATION METHODS MARKET IN NORTH AMERICA 93
FIGURE 22 NORTH AMERICA: BREAST LESION LOCALIZATION METHODS MARKET SNAPSHOT 94
TABLE 76 NORTH AMERICA: BREAST LESION LOCALIZATION METHODS MARKET,
BY COUNTRY, 2017–2019 (THOUSAND PROCEDURES) 94
TABLE 77 NORTH AMERICA: BREAST LESION LOCALIZATION METHODS MARKET,
BY COUNTRY, 2020–2025 (THOUSAND PROCEDURES) 95
TABLE 78 NORTH AMERICA: BREAST LESION LOCALIZATION METHODS MARKET,
BY TYPE, 2017–2019 (THOUSAND PROCEDURES) 95
TABLE 79 NORTH AMERICA: BREAST LESION LOCALIZATION METHODS MARKET,
BY TYPE, 2020–2025 (THOUSAND PROCEDURES) 95
TABLE 80 NORTH AMERICA: RADIOISOTOPE LOCALIZATION METHODS MARKET,
BY TYPE, 2017–2019 (THOUSAND PROCEDURES) 96
TABLE 81 NORTH AMERICA: RADIOISOTOPE LOCALIZATION METHODS MARKET,
BY TYPE, 2020–2025 (THOUSAND PROCEDURES) 96
TABLE 82 NORTH AMERICA: BREAST LESION LOCALIZATION METHODS MARKET,
BY USAGE, 2017–2019 (THOUSAND PROCEDURES) 96
TABLE 83 NORTH AMERICA: BREAST LESION LOCALIZATION METHODS MARKET,
BY USAGE, 2020–2025 (THOUSAND PROCEDURES) 96
TABLE 84 NORTH AMERICA: BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE IDENTIFICATION, BY SURGERY TYPE, 2017–2019 (THOUSAND PROCEDURES) 97
TABLE 85 NORTH AMERICA: BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE IDENTIFICATION, BY SURGERY TYPE,
2020–2025 (THOUSAND PROCEDURES) 97
TABLE 86 NORTH AMERICA: BREAST LESION LOCALIZATION METHODS MARKET,
BY TYPE, 2017–2019 (USD MILLION) 97
TABLE 87 NORTH AMERICA: BREAST LESION LOCALIZATION METHODS MARKET,
BY TYPE, 2020–2025 (USD MILLION) 98
9.4.2 US 98
9.4.2.1 US to dominate the North American breast lesion localization market 98
TABLE 88 US: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE,
2017–2019 (THOUSAND PROCEDURES) 99
TABLE 89 US: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE,
2020–2025 (THOUSAND PROCEDURES) 99
TABLE 90 US: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE,
2017–2019 (THOUSAND PROCEDURES) 99
TABLE 91 US: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE,
2020–2025 (THOUSAND PROCEDURES) 100
TABLE 92 US: BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE,
2017–2019 (THOUSAND PROCEDURES) 100
TABLE 93 US: BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE,
2020–2025 (THOUSAND PROCEDURES) 100
TABLE 94 US: BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE IDENTIFICATION, BY SURGERY TYPE, 2017–2019 (THOUSAND PROCEDURES) 100
TABLE 95 US: BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE IDENTIFICATION, BY SURGERY TYPE, 2020–2025 (THOUSAND PROCEDURES) 101
TABLE 96 US: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE,
2017–2019 (USD MILLION) 101
TABLE 97 US: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE,
2020–2025 (USD MILLION) 101
9.4.3 CANADA 102
9.4.3.1 Increasing incidence of breast cancer and government initiatives for breast cancer awareness to drive market growth in Canada 102
TABLE 98 CANADA: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017–2019 (THOUSAND PROCEDURES) 102
TABLE 99 CANADA: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2020–2025 (THOUSAND PROCEDURES) 103
TABLE 100 CANADA: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE,
2017–2019 (THOUSAND PROCEDURES) 103
TABLE 101 CANADA: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE,
2020–2025 (THOUSAND PROCEDURES) 103
TABLE 102 CANADA: BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2017–2019 (THOUSAND PROCEDURES) 103
TABLE 103 CANADA: BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE, 2020–2025 (THOUSAND PROCEDURES) 104
TABLE 104 CANADA: BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE IDENTIFICATION, BY SURGERY TYPE, 2017–2019 (THOUSAND PROCEDURES) 104
TABLE 105 CANADA: BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE IDENTIFICATION, BY SURGERY TYPE, 2020–2025 (THOUSAND PROCEDURES) 104
TABLE 106 CANADA: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2017–2019 (USD MILLION) 104
TABLE 107 CANADA: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE, 2020–2025 (USD MILLION) 105
9.5 REST OF THE WORLD 105
9.5.1 COVID-19 IMPACT ON THE BREAST LESION LOCALIZATION METHODS MARKET IN THE REST OF THE WORLD 105
TABLE 108 ROW: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE,
2017–2019 (THOUSAND PROCEDURES) 106
TABLE 109 ROW: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE,
2020–2025 (THOUSAND PROCEDURES) 106
TABLE 110 ROW: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE,
2017- 2019 (THOUSAND PROCEDURES) 106
TABLE 111 ROW: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE,
2020–2025 (THOUSAND PROCEDURES) 107
TABLE 112 ROW: BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE,
2017–2019 (THOUSAND PROCEDURES) 107
TABLE 113 ROW: BREAST LESION LOCALIZATION METHODS MARKET, BY USAGE,
2020–2025 (THOUSAND PROCEDURES) 107
TABLE 114 ROW: BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE IDENTIFICATION, BY SURGERY TYPE,
2017–2019 (THOUSAND PROCEDURES) 107
TABLE 115 ROW: BREAST LESION LOCALIZATION METHODS MARKET FOR SENTINEL LYMPH NODE IDENTIFICATION, BY SURGERY TYPE,
2020–2025 (THOUSAND PROCEDURES) 108
TABLE 116 ROW: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE,
2017–2019 (USD MILLION) 108
TABLE 117 ROW: BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE,
2020–2025 (USD MILLION) 108
10 COMPETITIVE LANDSCAPE 109
10.1 INTRODUCTION 109
FIGURE 23 KEY DEVELOPMENTS IN THE BREAST LESION LOCALIZATION METHODS MARKET 109
10.2 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET) 110
10.3 VENDOR INCLUSION CRITERIA 110
10.4 VENDOR DIVE 110
10.4.1 VISIONARY LEADERS 110
10.4.2 INNOVATORS 110
10.4.3 DYNAMIC DIFFERENTIATORS 110
10.4.4 EMERGING COMPANIES 111
FIGURE 24 VENDOR DIVE: EVALUATION OVERVIEW 111
10.5 GEOGRAPHICAL ASSESSMENT OF THE MAJOR PLAYERS IN THE BREAST LESION LOCALIZATION METHODS MARKET 112
10.6 COMPETITIVE ASSESSMENT OF R&D EXPENDITURE 112
FIGURE 25 R&D EXPENDITURE OF KEY PLAYERS, 2018 VS. 2019 (USD MILLION) 112
10.7 MARKET SHARE ANALYSIS 113
10.7.1 MARKET SHARE ANALYSIS: GLOBAL BREAST LESION LOCALIZATION METHODS MARKET 113
FIGURE 26 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SHARE,
BY KEY PLAYER, 2019 113
10.8 COMPETITIVE SCENARIO 114
TABLE 118 PRODUCT LAUNCHES 114
TABLE 119 ACQUISITIONS 114
TABLE 120 AGREEMENTS AND PARTNERSHIPS 114
10.9 BREAST LESION LOCALIZATION METHODS: COMPARATIVE ANALYSIS 115
10.10 BREAST LESION LOCALIZATION METHODS: COMPARATIVE ANALYSIS 116
FIGURE 27 COMPARATIVE ANALYSIS: DETECTION RATE, SUCCESS RATE, AND RE-EXCISION RATE 116
10.11 BREAST LESION LOCALIZATION METHODS: SELECTION CRITERIA EVALUATION 116
FIGURE 28 SELECTION CRITERIA EVALUATION 117
10.12 QUALITATIVE ASSESSMENT OF REPLACEMENT TRENDS 118
FIGURE 29 REPLACEMENT TRENDS 118
11 COMPANY PROFILES 119
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 HOLOGIC, INC. 119
FIGURE 30 HOLOGIC, INC.: COMPANY SNAPSHOT 119
11.2 BECTON, DICKINSON AND COMPANY 121
FIGURE 31 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 121
11.3 CIANNA MEDICAL, INC. 123
FIGURE 32 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT 123
11.4 LEICA BIOSYSTEMS 125
FIGURE 33 DANAHER: COMPANY SNAPSHOT (2019) 125
11.5 ARGON MEDICAL DEVICES, INC. 127
11.6 LAURANE MEDICAL 128
11.7 ENDOMAGNETICS LIMITED 129
11.8 HEALTH BEACONS, INC. 130
11.9 INTRA-MEDICAL IMAGING 131
11.10 ISOAID 132
11.11 SOMATEX MEDICAL TECHNOLOGIES 133
11.12 SURGICEYE GMBH 135
11.13 RANFAC CORPORATION 136
11.14 MERMAID MEDICAL GROUP 137
11.15 IZI MEDICAL 138
11.16 MATEK MEDICAL INC. 139
11.17 TSUNAMI MEDICAL 140
11.18 BPB MEDICA 141
11.19 SIRIUS MEDICAL BV 142
11.20 MOLLI SURGICAL INC. 143
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 ADJACENT/RELATED MARKET – BREAST IMAGING MARKET 144
12.1 INTRODUCTION 144
12.2 BREAST IMAGING MARKET 144
12.2.1 MARKET DEFINITION 144
12.2.2 LIMITATIONS 144
12.2.3 MARKET OVERVIEW 144
12.3 BREAST IMAGING MARKET, BY REGION 145
TABLE 121 BREAST IMAGING MARKET, BY REGION, 2016–2023 (USD MILLION) 145
12.4 BREAST IMAGING MARKET, BY TECHNOLOGY 145
TABLE 122 BREAST IMAGING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 145
12.4.1 IONIZING BREAST IMAGING TECHNOLOGIES MARKET 146
TABLE 123 IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2016–2023 (USD MILLION) 146
TABLE 124 IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY REGION, 2016–2023 (USD MILLION) 146
12.4.2 MAMMOGRAPHY 146
TABLE 125 MAMMOGRAPHY MARKET, BY TYPE, 2016–2023 (USD MILLION) 147
TABLE 126 MAMMOGRAPHY MARKET, BY REGION, 2016–2023 (USD MILLION) 147
12.4.3 POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY (PET-CT) 147
12.4.3.1 Combined scans from PET and CT provide a more accurate diagnosis as compared to the individual scans performed 147
TABLE 127 POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY MARKET,
BY REGION, 2016–2023 (USD MILLION) 148
12.4.4 MOLECULAR BREAST IMAGING 148
12.4.4.1 MBI technique is simple, fast, and highly sensitive and can be used for patients who are claustrophobic or allergic to gadolinium 148
TABLE 128 MOLECULAR BREAST IMAGING MARKET, BY REGION,
2016–2023 (USD MILLION) 149
12.4.5 POSITRON EMISSION MAMMOGRAPHY 149
12.4.5.1 PEM involves radiation exposure throughout the body, which increases the risk of cancer—a major disadvantage associated with this technique 149
TABLE 129 POSITRON EMISSION MAMMOGRAPHY MARKET, BY REGION,
2016–2023 (USD MILLION) 150
12.5 NON-IONIZING BREAST IMAGING TECHNOLOGIES 150
TABLE 130 NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE,
2016–2023 (USD MILLION) 150
TABLE 131 NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY REGION, 2016–2023 (USD MILLION) 151
12.5.1 BREAST ULTRASOUND 151
12.5.1.1 Lower cost, increasing awareness, and easy availability of ultrasound devices for breast imaging are driving the growth of this market 151
TABLE 132 BREAST ULTRASOUND MARKET, BY REGION, 2016–2023 (USD MILLION) 152
12.5.2 BREAST MRI 152
12.5.2.1 Technological advancements in breast MRI and the rising demand for technologies that involve minimal use of radiation are the key factors driving the growth of this market 152
TABLE 133 BREAST MRI MARKET, BY REGION, 2016–2023 (USD MILLION) 153
12.5.3 AUTOMATED WHOLE-BREAST ULTRASOUND 153
12.5.3.1 AWBU helps spot tiny cancers in the mammogram of fatty breasts 153
TABLE 134 AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY REGION,
2016–2023 (USD MILLION) 154
12.5.4 BREAST THERMOGRAPHY 154
12.5.4.1 This technique is not effective when used as a standalone test for breast cancer screening 154
TABLE 135 BREAST THERMOGRAPHY MARKET, BY REGION, 2016–2023 (USD MILLION) 154
12.6 OTHER BREAST IMAGING TECHNOLOGIES 155
12.6.1 OPTICAL IMAGING 155
12.6.2 CONE-BEAM COMPUTED TOMOGRAPHY 155
12.6.3 ELECTRIC IMPEDANCE TOMOGRAPHY 155
TABLE 136 BREAST IMAGING MARKET FOR OTHER TECHNOLOGIES, BY REGION,
2016–2023 (USD MILLION) 156
13 APPENDIX 157
13.1 DISCUSSION GUIDE 157
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 160
13.3 AVAILABLE CUSTOMIZATIONS 162
13.4 RELATED REPORTS 162
13.5 AUTHOR DETAILS 163



★調査レポート[乳房病変位置特定法の世界市場予測:種類別(ワイヤー、ラジオアイソトープ[ラジオオカルト]、磁気)、使用別(腫瘍特定、センチネルリンパ節[乳腺腫瘍摘出術])、エンドユーザー別(選択基準、交換傾向)] ( Breast Lesion Localization Methods Market By Type (Wire, Radioisotope [Radio Occult], Magnetic), Usage (Tumor Identification, Sentinel Lymph Node [Lumpectomy]), End User Preference Survey (Selection Criteria, Replacement Trend) - Global Forecast to 2025 / MD 4236) 販売に関する免責事項
[乳房病変位置特定法の世界市場予測:種類別(ワイヤー、ラジオアイソトープ[ラジオオカルト]、磁気)、使用別(腫瘍特定、センチネルリンパ節[乳腺腫瘍摘出術])、エンドユーザー別(選択基準、交換傾向)] ( Breast Lesion Localization Methods Market By Type (Wire, Radioisotope [Radio Occult], Magnetic), Usage (Tumor Identification, Sentinel Lymph Node [Lumpectomy]), End User Preference Survey (Selection Criteria, Replacement Trend) - Global Forecast to 2025 / MD 4236) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆